Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models
- PMID: 20220767
- PMCID: PMC3128718
- DOI: 10.1038/jid.2010.36
Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models
Abstract
To further elucidate molecular alterations in psoriasis, we performed a gene expression study of 58 paired lesional and uninvolved psoriatic and 64 control skin samples. Comparison of involved psoriatic (PP) and normal (NN) skin identified 1,326 differentially regulated transcripts encoding 918 unique genes (549 up- and 369 downregulated), of which over 600 are to our knowledge previously unreported, including S100A7A, THRSP, and ELOVL3. Strongly upregulated genes included SERPINB4, PI3, DEFB4, and several S100-family members. Strongly downregulated genes included Wnt-inhibitory factor-1 (WIF1), beta-cellulin (BTC), and CCL27. Enriched gene ontology categories included immune response, defense response, and keratinocyte differentiation. Biological processes regulating fatty acid and lipid metabolism were enriched in the down-regulated gene set. Comparison of the psoriatic transcriptome to the transcriptomes of cytokine-stimulated cultured keratinocytes (IL-17, IL-22, IL-1alpha, IFN-gamma, TNF-alpha, and OSM) showed surprisingly little overlap, with the cytokine-stimulated keratinocyte expression representing only 2.5, 0.7, 1.5, 5.6, 5.0, and 1.9% of the lesional psoriatic dysregulated transcriptome, respectively. This comprehensive analysis of differentially regulated transcripts in psoriasis provides additional insight into the pathogenic mechanisms involved and emphasizes the need for more complex yet tractable experimental models of psoriasis.
Conflict of interest statement
Figures






Similar articles
-
The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis.Am J Pathol. 2007 Jul;171(1):32-42. doi: 10.2353/ajpath.2007.061067. Am J Pathol. 2007. PMID: 17591951 Free PMC article.
-
Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms.J Invest Dermatol. 2014 Jul;134(7):1828-1838. doi: 10.1038/jid.2014.28. Epub 2014 Jan 17. J Invest Dermatol. 2014. PMID: 24441097 Free PMC article.
-
Evidence for altered Wnt signaling in psoriatic skin.J Invest Dermatol. 2010 Jul;130(7):1849-59. doi: 10.1038/jid.2010.67. Epub 2010 Apr 8. J Invest Dermatol. 2010. PMID: 20376066 Free PMC article.
-
Transcriptome Profiling Analyses in Psoriasis: A Dynamic Contribution of Keratinocytes to the Pathogenesis.Genes (Basel). 2020 Sep 30;11(10):1155. doi: 10.3390/genes11101155. Genes (Basel). 2020. PMID: 33007857 Free PMC article. Review.
-
Pathogenesis of psoriasis.Dermatol Clin. 1995 Oct;13(4):723-37. Dermatol Clin. 1995. PMID: 8785878 Review.
Cited by
-
Cytokines in psoriasis.Cytokine. 2015 Jun;73(2):342-50. doi: 10.1016/j.cyto.2014.12.014. Epub 2015 Jan 10. Cytokine. 2015. PMID: 25585875 Free PMC article. Review.
-
Differentially Expressed Cell Cycle Genes and STAT1/3-Driven Multiple Cancer Entanglement in Psoriasis, Coupled with Other Comorbidities.Cells. 2022 Nov 30;11(23):3867. doi: 10.3390/cells11233867. Cells. 2022. PMID: 36497125 Free PMC article.
-
In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine.Theranostics. 2019 Apr 13;9(9):2475-2488. doi: 10.7150/thno.31144. eCollection 2019. Theranostics. 2019. PMID: 31131048 Free PMC article.
-
NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis.Sci Rep. 2016 Mar 15;6:22745. doi: 10.1038/srep22745. Sci Rep. 2016. PMID: 26976200 Free PMC article.
-
Overview of the molecular determinants contributing to the expression of Psoriasis and Psoriatic Arthritis phenotypes.J Cell Mol Med. 2020 Dec;24(23):13554-13563. doi: 10.1111/jcmm.15742. Epub 2020 Oct 31. J Cell Mol Med. 2020. PMID: 33128843 Free PMC article. Review.
References
-
- Akey JM, Biswas S, Leek JT, Storey JD. On the design and analysis of gene expression studies in human populations. Nat Genet. 2007;39:807–8. author reply 8-9. - PubMed
-
- Alkemade JA, Molhuizen HO, Ponec M, Kempenaar JA, Zeeuwen PL, de Jongh GJ, et al. SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. J Cell Sci. 1994;107(Pt 8):2335–42. - PubMed
-
- Bando M, Hiroshima Y, Kataoka M, Shinohara Y, Herzberg MC, Ross KF, et al. Interleukin-1alpha regulates antimicrobial peptide expression in human keratinocytes. Immunol Cell Biol. 2007;85:532–7. - PubMed
-
- Banno T, Adachi M, Mukkamala L, Blumenberg M. Unique keratinocyte-specific effects of interferon-gamma that protect skin from viruses, identified using transcriptional profiling. Antivir Ther. 2003;8:541–54. - PubMed
-
- Banno T, Gazel A, Blumenberg M. Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem. 2004;279:32633–42. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous